TauroLock U25.000
Antimicrobial catheter lock solution
TauroLock™-U25.000 has been approved for installation in all central venous access systems. This lock solution reliably prevents the formation of bacterial biofilms within catheters, allowing patients to avoid infections and maintain a high patency rate.
TauroLock™-U25.000 is based on three active ingredients:
- Taurolidine
- Citrate (4 %)
- Urokinase (25,000 units)
aurolidine has a broad antimicrobial activity (incl. MRSA and VRE), while citrate works as an anticoagulant.
Urokinase has a thrombolytic effect, breaking up blood clotting in its early stages.
Essential Care, Exceptional Solutions
We are dedicated to providing innovative solutions for anesthesia management.
Equipping intensive care units with cutting-edge technology to ensure the highest level of care for critically ill patients.
Providing innovative vital signs monitoring solutions, blood transfusion & drug infusion devices, specialized CVC catheters and more to ensure optimal care for neonates and pediatric patients.
Unparalleled signal quality for ECG measurements.
Conclusive solutions for prevention of infections.